204
Participants
Start Date
August 1, 2023
Primary Completion Date
July 20, 2024
Study Completion Date
August 19, 2024
Solriamfetol
solriamfetol : QD,PO,Day 1-Day 84;
Placebo
Placebo :QD,PO,Day 1-Day 84
Shanghai Sixth People's Hospital, Shanghai
Beijing TianTan Hospital Capital Medical University, Beijing
China-Japan friendship Hospital, Beijing
Peking University Sixth Hospital, Beijing
XuanWu Hospital Capital Medical University, Beijing
The first hospital of Jilin University, Changchun
Xiangya Hospital Central South University, Changsha
ChongQing University three gorges Hospital, Chongqing
The Hospital Group of the First Affiliated Hospital of CQMU, Chongqing
GanSU Provincial Hospital, Gansu
The first affiliated hospital of Guangzhou Medical University, Guangzhou
The first affiliated hospital of JiNan University, Guangzhou
Hangzhou seventh People's Hospital, Hangzhou
The first hospital of Hebei Medical University, Hebei
Huai'an First People's Hospital, Huai'an
The Second Affiliated Hospital of Nanchang University, Nanchang
The Fitst Affiliated Hospital of NingBo University, Ningbo
ShanDong Provincial QianFoShan Hospital, Shandong
HuaShan Hospital FuDan University, Shanghai
First hospital of ShanXi Medical University, Shanxi
Second hospital of Shanxi Medical University, Shanxi
ShenZhen People's Hospital, Shenzhen
West China fourth Hospital Sichuan University, Sichuan
The Second Affiliated Hospital of Suzhou University, Suzhou
Yan'an University Xianyang Hospital, Xianyang
The First People's Hospital of YunNan Province, Yunnan
Ignis Therapeutics (Suzhou) Limited
INDUSTRY